Unique ID issued by UMIN | UMIN000021903 |
---|---|
Receipt number | R000024761 |
Scientific Title | Identifying of index cancer among multiple cancer foci by methylation analysis using the ex vivo prostate needle biopsy from prostatectomy specimen |
Date of disclosure of the study information | 2016/06/01 |
Last modified on | 2019/10/18 17:33:33 |
Identifying of index cancer among multiple cancer foci by methylation analysis using the ex vivo prostate needle biopsy from prostatectomy specimen
Identifying of index cancer by the prostate needle biopsy
Identifying of index cancer among multiple cancer foci by methylation analysis using the ex vivo prostate needle biopsy from prostatectomy specimen
Identifying of index cancer by the prostate needle biopsy
Japan |
prostate cancer
Urology |
Malignancy
YES
To identify the index cancer which determine the patient prognosis among the multiple prostate cancer foci with methylation analysis using an ex vivo needle biopsy specimens to compare between prostate normal tissue and prostate cancer tissue
Bio-equivalence
Confirmatory
Others
To identify the index cancer which determine the patient prognosis among the multiple prostate cancer foci with methylation analysis using ex vivo needle biopsy specimens to compare between prostate normal tissue and prostate cancer tissue
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Gene |
Methylation analysis of prostate normal tissue and cancer tissue from multiple cancer foci, which are taken from ex vivo prostatectomy specimens by needle biopsy technique
20 | years-old | <= |
90 | years-old | >= |
Male
Inclusion criteria:
1) The patients who had histologically-confirmed prostate adenocarcinoma, agreed to undergo radical prostatectomy.
2) The patients had MR-visible prostate cancer lesion, confirmed by MRUS fusion biopsy.
3) The patients signed by themselves the informed consent document after understanding this study.
Exclusion criteria:.
1) Prior or concurrent chemotherapy or androgen deprivation therapy for the prostate cancer.
2) Prior radiotherapy to the prostate or lower pelvis
3) Concurrent systemic steroids therapy for different disease
4) Unsuitable for participant due to mental disorder
5) The attending physician has determined inappropriate
10
1st name | |
Middle name | |
Last name | Osamu Ukimura |
Kyoto Prefectural University of Medicine
Urology
Kajiicho465 Kamigyoku Kyoto
075-251-5595
uro@koto.kpu-m.ac.jp
1st name | |
Middle name | |
Last name | Masakatsu Oishi |
Kyoto Prefectural University of Medicine
Urology
Kajiicho465 Kamigyoku Kyoto
075-251-5595
uro@koto.kpu-m.ac.jp
The department of Urology, Kyoto Prefectural University of Medicine
The department of Urology, Kyoto Prefectural University of Medicine
Other
NO
2016 | Year | 06 | Month | 01 | Day |
Unpublished
Open public recruiting
2016 | Year | 04 | Month | 01 | Day |
2016 | Year | 11 | Month | 29 | Day |
2016 | Year | 12 | Month | 13 | Day |
2022 | Year | 03 | Month | 31 | Day |
2016 | Year | 04 | Month | 14 | Day |
2019 | Year | 10 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024761